MINK Trademark

Trademark Overview


On Thursday, June 17, 2021, a trademark application was filed for MINK with the United States Patent and Trademark Office. The USPTO has given the MINK trademark a serial number of 90779238. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, June 14, 2024. This trademark is owned by AgenTus Therapeutics, Inc.. The MINK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biological preparations, namely, cell therapies for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease

Pharmaceutical, medical, scientific, and biopharmaceutical research and development
mink

General Information


Serial Number90779238
Word MarkMINK
Filing DateThursday, June 17, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, June 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Goods and ServicesCells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease; biological preparations, namely, cell therapies for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections, and inflammatory disease
Goods and ServicesPharmaceutical, medical, scientific, and biopharmaceutical research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, March 16, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMINK THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Party NameMINK THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02421

Party NameAgenTus Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Thursday, September 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 17, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 9, 2022ASSIGNED TO EXAMINER
Wednesday, March 9, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 9, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 15, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 21, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 21, 2022SOU EXTENSION 1 FILED
Wednesday, December 21, 2022SOU EXTENSION 1 GRANTED
Friday, December 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 20, 2023SOU EXTENSION 2 FILED
Tuesday, June 20, 2023SOU EXTENSION 2 GRANTED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 15, 2023SOU EXTENSION 3 FILED
Friday, December 15, 2023SOU EXTENSION 3 GRANTED
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2024SOU EXTENSION 4 GRANTED
Friday, June 14, 2024SOU EXTENSION 4 FILED